Related Experiment Video
Updated: Aug 31, 2026

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
CTCF gene mutations in invasive ductal breast cancer
Sebastian Aulmann1, Hendrik Bläker, Roland Penzel
1Department of Pathology, University of Heidelberg, Germany. sebastian_aulmann@med.uni-heidelberg.de
Abstract:
The CTCF gene encodes for a transcriptional repressor of the c-myc oncogene and has previously been mapped to one of the smallest regions of overlapping interstitial deletions on chromosome 16q22.1 in invasive breast cancer. This chromosomal region is frequently deleted in both invasive lobular and ductal breast carcinomas. However, no target genes have been identified in invasive ductal breast cancer. We examined CTCF protein expression in 18 invasive ductal breast carcinomas using immunohistochemistry. Additionally, loss of heterozygosity (LOH) at chromosome 16q22.1 was determined and the complete cDNA sequence of CTCF was screened for mutations. Immunohistochemically, 17 tumours showed a moderate to strong nuclear staining for CTCF, one case was completely negative. Sequencing analysis revealed a tumour-specific truncating 14 bp insertion with silencing of the wild type allele in this case. In one further case we found a missense mutation that was shown not to be tumour-specific. Concordant with the antiproliferative effects of the CTCF protein in vivo, CTCF may be involved in tumour initiation or proliferation in individual cases of invasive ductal breast carcinoma.
Insights
CTCF, a c-myc repressor, is frequently deleted in breast cancer. A truncating mutation in CTCF was found in one invasive ductal breast carcinoma case, suggesting its role in tumor development.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The CTCF gene, a transcriptional repressor of the c-myc oncogene, is located on chromosome 16q22.1.
- This region is frequently deleted in invasive lobular and ductal breast carcinomas.
- CTCF's role in invasive ductal breast cancer (IDBC) remains unclear.
Purpose of the Study:
- To investigate CTCF protein expression and genetic alterations in IDBC.
- To determine if CTCF is a target gene in IDBC.
Main Methods:
- Immunohistochemistry was used to assess CTCF protein expression in 18 IDBC tumors.
- Loss of heterozygosity (LOH) analysis was performed on chromosome 16q22.1.
- The CTCF cDNA sequence was screened for mutations.
Main Results:
- CTCF protein was moderately to strongly expressed in 17 out of 18 tumors.
- One tumor showed complete loss of CTCF staining.
- Sequencing revealed a tumor-specific truncating mutation in CTCF in the negative case, silencing the wild-type allele.
- A non-tumor-specific missense mutation was identified in another case.
Conclusions:
- CTCF may play a role in tumor initiation or proliferation in a subset of invasive ductal breast carcinomas.
- The identified CTCF mutation provides evidence for its involvement in IDBC development.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

